Wave Life Sciences (WVE) Cash & Current Investments: 2015-2025
Historic Cash & Current Investments for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to $196.2 million.
- Wave Life Sciences' Cash & Current Investments fell 36.90% to $196.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $949.9 million, marking a year-over-year increase of 12.25%. This contributed to the annual value of $302.1 million for FY2024, which is 50.77% up from last year.
- Per Wave Life Sciences' latest filing, its Cash & Current Investments stood at $196.2 million for Q3 2025, which was down 5.89% from $208.5 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Cash & Current Investments registered a high of $310.9 million during Q3 2024, and its lowest value of $88.5 million during Q4 2022.
- For the 3-year period, Wave Life Sciences' Cash & Current Investments averaged around $210.6 million, with its median value being $200.4 million (2023).
- In the last 5 years, Wave Life Sciences' Cash & Current Investments tumbled by 42.74% in 2021 and then spiked by 126.39% in 2023.
- Quarterly analysis of 5 years shows Wave Life Sciences' Cash & Current Investments stood at $150.6 million in 2021, then slumped by 41.22% to $88.5 million in 2022, then surged by 126.39% to $200.4 million in 2023, then skyrocketed by 50.77% to $302.1 million in 2024, then slumped by 36.90% to $196.2 million in 2025.
- Its Cash & Current Investments stands at $196.2 million for Q3 2025, versus $208.5 million for Q2 2025 and $243.1 million for Q1 2025.